Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company, has recently announced the acquisition of assets and liabilities of the Biopharma Services business of Cancer Genetics Inc. in a deal worth approx. $23.5 mil
Biotech companies Cytune Pharma and SOTIO have recently declared that they have initiated SO-C101 dosing of cancer patients. The phase I/Ib clinical trial will assess the preliminary efficacy and safety of SO-C101 in subjects with selected metastatic
The expected outcome of the PRIMROSE1 clinical trial is to establish a significant reduction in menstrual bleeding assessed by alkaline hematin method, the results of which is expected in 1H 2020.
ObsEva SA- a biopharmac
First out of eleven similar patents submitted cover different drug combinations.
Ares Genetics GmbH – a subsidiary of molecular diagnostic developer Curetis N.V. has reportedly been granted a patent from the European Pa
FDA approved the treatment under its accelerated approval program
Reports confirm that the U.S. Food and Drug Administration (FDA) has granted approval to Xpovio tablets in combination with the Dexamethasone, a type of corticoster
21 subjects with mCRPC were enrolled into one of six cohorts of ascending TRC253 doses.
The clinical stage biopharmaceutical firm TRACON Pharmaceuticals has reportedly announced an update on its TRC253 program for metastatic castr
The trial has also examined changes to best corrected visual acuity (BCVA) of patients.
The biotechnology company Bicycle Therapeutics has reportedly announced that it has successfully completed Oxurion’s Phase I clinical study
It would be the first ever late stage clinical trial for the treatment of WHIM syndrome
Reports confirm that X4 Pharmaceuticals Inc. has recently confirmed it has initiated 4WHIM, a pivotal Phase 3 global clinical study of mavorix
Results support treatment of osteoarthritis with UBX0101 for eliminating senescent cell
Unity Biotechnology, a biotech company involved in the development of therapeutics that can extend health span of patients, recently announced